XML 15 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 31,062 $ 51,536
Short-term marketable securities 57,682 0
Trade receivables, net of allowances 15,300 9,860
Other receivable (Note 11) 12,896 0
Inventory 4,576 2,329
Prepaid expenses and other current assets 2,669 1,964
Total current assets 124,185 65,689
Strategic inventory 3,800 2,835
Property and equipment, net of accumulated depreciation 518 205
Long-term marketable securities 15,281 0
Other assets 50 24
Deferred tax assets, net 76,703 0
Total assets 220,537 68,753
Current liabilities:    
Accounts payable 8,579 2,290
Accrued clinical expenses 2,247 1,467
Other accrued liabilities 18,743 8,953
Debt obligation - current portion 0 14,664
Total current liabilities 29,569 27,374
Commitments and contingencies (Note 11)
Stockholders’ equity:    
Preferred stock, par value $0.001 per share, 10,000 shares authorized and no shares outstanding at December 31, 2017 and December 31, 2016
Common stock, par value $0.001 per share, 280,000 shares authorized and 114,717 and 112,710 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively 115 113
Additional paid-in capital 384,074 363,534
Accumulated other comprehensive loss (75) 0
Accumulated deficit (193,146) (322,268)
Total stockholders’ equity 190,968 41,379
Total liabilities and stockholders’ equity $ 220,537 $ 68,753